Peroxisome proliferator activated receptors and obesity

Author： Kersten S.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.440, Iss.2, 2002-04, pp. : 223-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 297-298

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes

By ŠŠeda Ondøøřřej   ŠŠedováá Lucie  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 587-596

Future Medicine

Access to resources Recommend Favorite

Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

By Esposito Emanuela   Cuzzocrea Salvatore  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 8, 2011-08 ,pp. : 943-959

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

By Paola Rosanna   Cuzzocrea Salvatore  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 3, 2007-05 ,pp. : 157-175

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and the Control of Fatty Acid Oxidation in Cardiac Hypertrophy

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 357-363

Bentham Science Publishers

Access to resources Recommend Favorite